Exchange Traded Concepts, LLC Protagonist Therapeutics, Inc Transaction History
Exchange Traded Concepts, LLC
- $5.43 Billion
- Q1 2025
A detailed history of Exchange Traded Concepts, LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 27,392 shares of PTGX stock, worth $1.38 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
27,392
Previous 1,025
2572.39%
Holding current value
$1.38 Million
Previous $39,000
3294.87%
% of portfolio
0.02%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PTGX
# of Institutions
299Shares Held
61.3MCall Options Held
1.01MPut Options Held
555K-
Farallon Capital Management LLC San Francisco, CA6.11MShares$307 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$289 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.72MShares$287 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.28MShares$215 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$151 Million5.07% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.47B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...